跳至主要内容
临床试验/NCT07255131
NCT07255131招募中不适用

The Effectiveness and Efficacy of an Online Group Cognitive Behavioral Psychotherapy in Patients With Cystic Fibrosis and Caregivers in Comparison to Control Groups by the Hellenic Cystic Fibrosis Association A Randomized Controlled Trial

Rakitzi, Stavroula1 个研究点 分布在 1 个国家目标入组 52 人开始时间: 2025年9月26日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
52
试验地点
1
主要终点
SRSDA

研究概览

简要总结

An online group cognitive behavioral psychotherapeutic program will be offered to patients with cystic fibrosis and to caregivers by the Hellenic Cystic Fibrosis Association. These 2 above therapy groups will be compared with control groups in a randomized controlled trial

详细描述

A therapy group of patients with cystic fibrosis, who participate on the online group cognitive behavioral psychotherapeutic program will be compared with a control group of patients with cystic fibrosis, who participate in an online group supportive psychotherapeutic program. Both of the groups participate on 13 sessions once a week.

A therapy group of caregivers, who participate on the online group cognitive behavioral psychotherapeutic program will be compared with a control group of caregivers, who participate in an online group supportive psychotherapeutic program. Both of the groups participate on 13 sessions once a week.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age 18-70
  • Members of the Hellenic Cystic Fibrosis Association
  • Willingness to participate on 13 sessions via Zoom

排除标准

  • Age over 70
  • Not members of the Hellenic Cystic Fibrosis Association
  • Not able to participate on 13 sessions via Zoom

研究组 & 干预措施

Therapy group A patients with Cystic Fibrosis

Experimental

Participation on an online group cognitive behavioral psychotherapy via Zoom in 13 sessions.

3 participants

干预措施: Group A An online group cognitive behavioral psychotherapy in 13 sessions via Zoom (Behavioral)

Control group B Patients with cystic fibrosis

Active Comparator

Participation on an online group supportive psychotherapy via Zoom in 13 sessions.

2 participants

干预措施: Group B An online group supportive psychotherapy in 13 sessions via Zoom (Behavioral)

Therapy group C caregivers of patients with cystic fibrosis

Experimental

Participation on an online group cognitive behavioral psychotherapy via Zoom in 13 sessions.

2 participants

干预措施: Group C An online group cognitive behavioral psychotherapy in 13 sessions via Zoom (Behavioral)

Contol group D caregivers of patients with cystic fibrosis

Active Comparator

Participation on an online group supportive psychotherapy via Zoom in 13 sessions.

2 participants

干预措施: Group D An online group supportive psychotherapy in 13 sessions via Zoom (Behavioral)

结局指标

主要结局

SRSDA

时间窗: Follow-up up to 24 weeks

It measures Depression. Minimum 0 Maximum over 14. Low scores better

SCL-90-R

时间窗: Follow-up up to 24 weeks

It evaluates psychopathology. T\>60 means psychopathology. Low scores better

U Uncertainty questionnaire

时间窗: Follow up up to 24 weeks

It evaluates social skills and assertiveness.: fear of criticism (psychopathology in \>35), fear of contact (psychopathology in \>41) , assertiveness (psychopathology in \<26) , difficulty of saying no (psychopathology in \>28) , guilt and decency (psychopathology in \>9)

Hamilton Depression Scale

时间窗: Follow up up to 24 weeks

It measures depression. Minimum 0, maximum 23. Low scores better.

WHODAS total

时间窗: Follow up up to 24 weeks

It measures functional outcome. Minimum 0, maximum 100. low scores better.

RAS-DS total

时间窗: Follow up up to 24 weeks

Recovery. It measures recovery. Minimum 0, maximum 152. High scores better.

SCL-90-R

时间窗: Preintervention

It evaluates psychopathology. T\>60 means psychopathology. Low scores better

SCL-90-R

时间窗: Immediately after the intervention

It evaluates psychopathology. T\>60 means psychopathology. Low scores better

SRSDA

时间窗: Preintervention

It measures Depression. Minimum 0 Maximum over 14. Low scores better

SRSDA

时间窗: Immediately after intervention

It measures Depression. Minimum 0 Maximum over 14. Low scores better

U Uncertainty questionnaire

时间窗: Preintervention

It evaluates social skills and assertiveness.: fear of criticism (psychopathology in \>35), fear of contact (psychopathology in \>41) , assertiveness (psychopathology in \<26) , difficulty of saying no (psychopathology in \>28) , guilt and decency (psychopathology in \>9)

U Uncertainty questionnaire

时间窗: Immediately after the intervention

It evaluates social skills and assertiveness.: fear of criticism (psychopathology in \>35), fear of contact (psychopathology in \>41) , assertiveness (psychopathology in \<26) , difficulty of saying no (psychopathology in \>28) , guilt and decency (psychopathology in \>9)

Hamilton Depression Scale

时间窗: Preintervention

It measures depression. Minimum 0, maximum 23. Low scores better.

Hamilton Depression Scale

时间窗: Immediately after the intervention

It measures depression. Minimum 0, maximum 23. Low scores better.

WHODAS total

时间窗: Preintervention

It measures functional outcome. Minimum 0, maximum 100. low scores better.

WHODAS total

时间窗: Immediately after the intervention

It measures functional outcome. Minimum 0, maximum 100. low scores better.

RAS-DS total

时间窗: Preintervention

Recovery. It measures recovery. Minimum 0, maximum 152. High scores better.

RAS-DS total

时间窗: Immediately after intervention

Recovery. It measures recovery. Minimum 0, maximum 152. High scores better.

次要结局

未报告次要终点

研究者

发起方
Rakitzi, Stavroula
申办方类型
Other
责任方
Principal Investigator
主要研究者

Dr. Stavroula Rakitzi

PhD, Clinical psychologist and cognitive behavioral psychotherapist

Rakitzi, Stavroula

研究点 (1)

Loading locations...

相似试验